3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
24
Myelodysplastic Syndromes
5
Myeloproliferative Disorders
3
Leukemia, Biphenotypic, Acute
3
Leukemia, Myeloid
2
Leukemia
2
Blast Crisis
2
Sarcoma, Myeloid
1
Neoplasms by Histologic Type
1
Myelodysplastic-Myeloproliferative Diseases
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hematologic Neoplasms
1
Carcinoma, Hepatocellular
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Cyclophosphamide
4
fludarabine
3
pembrolizumab
2
Specimen Handling
2
Radiation
2
Magnetic Resonance Spectroscopy
2
Doxorubicin
2
peposertib
1
pazopanib
1
olaparib
1
lutetium Lu 177 dotatate
1
liposomal doxorubicin
1
fludarabine phosphate
1
X-Rays
1
Radiotherapy
1
Phantoms, Imaging
1
Leukapheresis
1
Ifosfamide
1
CLR1404
1
Biopsy
1
ALT-803
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma, Synovial
×
Idarubicin
×
90 days
×
Clear all
No trials found.